E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Announces Issuance of Two New U.S. Patents
07 déc. 2022 08h00 HE | electroCore, Inc.
ROCKAWAY, N.J., Dec. 07, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the United States Patent and Trademark...
New Logo July 12, 2022.png
Odyssey Health, Inc. Provides Update on Company and the Progress of Concussion Drug Development
23 nov. 2022 08h30 HE | Odyssey Health, Inc
Las Vegas, Nevada, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
gammaCore Sapphire™ Non-Invasive Vagus Nerve Stimulator (nVNS) Receives Unique National Product Code Number by the Belgian Pharmaceutical Association
18 nov. 2022 08h00 HE | electroCore, Inc.
ROCKAWAY, N.J., Nov. 18, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that gammaCore Sapphire has...
New Logo July 12, 2022.png
Odyssey Health, Inc. Schedules Annual Meeting of Stockholders
15 nov. 2022 08h00 HE | Odyssey Health, Inc
Las Vegas, Nevada, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc. (the "Company" or "Odyssey"), a medical technology company focused on...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore to Participate at Canaccord Genuity MedTech and Diagnostics and Digital Health & Services Forum
14 nov. 2022 16h05 HE | electroCore, Inc.
ROCKAWAY, N.J., Nov. 14, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that electroCore’s Chief Executive Officer, Dan...
Aviv-Clinic Logo.png
Aviv Clinics and America’s Mighty Warriors Partner to Provide Life-Changing Treatments to Veterans Suffering from Concussion, Traumatic Brain Injury
11 nov. 2022 09h12 HE | Aviv Clinics
ORLANDO, Fla., Nov. 11, 2022 (GLOBE NEWSWIRE) -- Aviv Clinics, the global leader in the research and treatment of brain conditions, today announces a pledge of $1 million in in-kind treatments to...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Announces Third Quarter 2022 Financial Results
03 nov. 2022 16h05 HE | electroCore, Inc.
Third quarter 2022 revenue grew 33% over third quarter 2021 Company to host a conference call and webcast today, November 3, 2022 at 4:30 pm EDT ROCKAWAY, N.J. , Nov. 03, 2022 (GLOBE NEWSWIRE) --...
New Logo July 12, 2022.png
Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma Through Expansion of Executive Team
03 nov. 2022 08h30 HE | Odyssey Health, Inc
Las Vegas, Nevada, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc. (the "Company" or "Odyssey"), a medical technology company focused on...
New Logo July 12, 2022.png
Odyssey Health Inc. Files Full US Patent Application on Novel Breath-Propelled Intranasal Brain-Drug Delivery Device
01 nov. 2022 08h30 HE | Odyssey Health, Inc
Las Vegas, Nevada, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc. (the "Company" or "Odyssey"), announces that it has filed for United...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore, Inc. Announces Distribution Agreement with Joerns Healthcare, LLC
01 nov. 2022 08h00 HE | electroCore, Inc.
ROCKAWAY, N.J., Nov. 01, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that gammaCore Sapphire™, the first and only...